Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Mitochondrial Complex V Dysfunction in Neurodegeneration: Secondary Bystander or Primary Driver?

Harris KE, Lascaratos G, Chau KY.

Brain Sci. 2026 Aug 20;16(8):890. doi: 10.3390/brainsci16080890.

Glutathione Biology in Neurodegenerative and Metabolic Diseases: Molecular Mechanisms, Pathophysiological Roles, and Therapeutic Perspectives

Gromadzka G, Kąkol M, Klimkiewicz M, Bendykowska M.

Int J Mol Sci. 2026 Aug 21;27(16):7507. doi: 10.3390/ijms27167507.

Ginsenosides: potential therapeutic implications in neurodegenerative diseases by inhibiting ferroptosis

Liu C, Zhang Y.

Mol Biol Rep. 2026 Aug 29;53(1):1497. doi: 10.1007/s11033-026-12673-2.

α2-3-sialylated glycosphingolipids in neuroinflammation, immunity, and programmed cell death: mechanistic evidence and context-dependent regulation: a comprehensive review

Li X, Li L, Liu X, Liu S, Yang W, Gao J, Kang S, Wang L, Li J, Wang X, Du H, Su S, Li Z, Xu W.

Front Immunol. 2026 Aug 19;17:1865721. doi: 10.3389/fimmu.2026.1865721. eCollection 2026.

An acute postpartum uterine inversion - a near miss case: challenges of management in a resource limited setting - a case report

Pelden T, Dorji N.

Int J Surg Case Rep. 2026 Jul 28;138(9):3517-3521. doi: 10.1097/RC9.0000000000000759. eCollection 2026 Sep.

Therapeutic potential of apigenin in neurodegenerative diseases and brain health

Aldiqs M, Aliev M, Gajjar TB, Senapati JN, Alhasso B, Urazbaeva D, Aminqulov S, Mishra MK.

Mol Biol Rep. 2026 Sep 5;53(1):1540. doi: 10.1007/s11033-026-12703-z.

P2X7 Receptor in Rare Diseases: Shared Molecular Mechanisms and Therapeutic Implications

Xiao X, Cao G, Hou S, Yin H.

J Inflamm Res. 2026 Sep 5;19:613821. doi: 10.2147/JIR.S613821. eCollection 2026.

The double-edged sentinel: cGAS-STING as a context-dependent regulator of microglial senescence and neuronal genotoxic stress in neurodegeneration

Zhang C, Yang Z.

Brain Res Bull. 2026 Oct 15;245:112118. doi: 10.1016/j.brainresbull.2026.112118. Epub 2026 Sep 16.

Defective membrane dynamics in Huntington's disease: A role of Rab11 dysfunction

Wu A, Li X.

J Huntingtons Dis. 2026 Sep 24:18796397261490952. doi: 10.1177/18796397261490952. Online ahead of print.

Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease

Malakar V, Malakar CC, Mali PC, Poddar NK.

Biochim Biophys Acta Proteins Proteom. 2026 Sep 18;1875(1):141177. doi: 10.1016/j.bbapap.2026.141177. Online ahead of print.

Navigating the Uncommon: "Juvenile-Onset Huntington Disease"

Aatli A, Saryan S, Sehgal R, Kashyap A, Gupta A.

J Child Neurol. 2026 Sep;41(8):1185-1189. doi: 10.1177/08830738251396171. Epub 2025 Dec 19.

Chorea-Acanthocytosis Without Acanthocytosis: Sensory Neuronopathy and Epilepsy as Prominent Features From a Novel VPS13A Variant

Tamaoui L, Bouhouche A, Birouk N.

Clin Genet. 2026 Oct;110(4):522-523. doi: 10.1111/cge.70223. Epub 2026 Aug 2.

A Systematic Review of the Vascular and Neuronal Role of L-Carnosine: Mechanistic and Pharmacological Perspectives

Tiwari N, Kumar V, Joshi BC, Saeedan AS, Rashid S, Ansari MN.

Curr Neuropharmacol. 2026 Aug 25. doi: 10.2174/011570159X462604260803095102. Online ahead of print.

Co-amoxicillin-induced reactivation of auto-brewery syndrome in a patient treated for community acquired pneumonia: a clinical case report

Widmer P, Miesch FA, Scotti B, Erni G, Sperb R.

Oxf Med Case Reports. 2026 Sep 8;2026(9):omag167. doi: 10.1093/omcr/omag167. eCollection 2026 Sep.

Management of Eprinomectin Neurotoxicosis in Cats

Mealey KL, Martin LG, Kastenholz VP.

J Vet Emerg Crit Care (San Antonio). 2026 Sep 16. doi: 10.1111/vec.70164. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias